Expanded IL-22+ Group 3 Innate Lymphoid Cells and Role of Oxidized LDL-C in the Pathogenesis of Axial Spondyloarthritis with Dyslipidaemia

키워드

참고문헌 (34)

1. Sieper J, "The Assessment of SpondyloArthritis international Society(ASAS)handbook : a guide to assess spondyloarthritis", Ann Rheum Dis, 68(Suppl 2), pp.ii1~ii44 (2009)
2. Ward MM, "2019 update of the American College of Rheumatology", Spondylitis Association of America, Arthritis Rheumatol, pp.2019, 71[DOI]
3. Smith JA, "Review : The interleukin-23", interleukin-17 axis in spondyloarthritis pathogenesis : Th17 and beyond, 2014, pp.66, 231~241
4. Deodhar A, "Three multicenter, randomized, double-blind, placebo-controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis", Arthritis Rheumatol, 71, pp.258~270 (2019)
5. Spits H, "Innate lymphoid cells--a proposal for uniform nomenclature", Nat Rev Immunol, 13, pp.145~149 (2013)
6. Vivier E, "Innate lymphoid cells : 10 years on", Cell, 174, pp.1054~1066 (2018)
7. Fang W, "Innate lymphoid cells in inflammatory arthritis", Arthritis Res Ther, 22, pp.25~ (2020)
8. Ciccia F, "Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis", Ann Rheum Dis, 74, pp.1739~1747 (2015)
9. Blijdorp IC, "Expansion of interleukin-22-and granulocyte-macrophage colony-stimulating factor-expressing, but not interleukin-17A-expressing, group 3 innate lymphoid cells in the inflamed joints of patients with spondyloarthritis", Arthritis Rheumatol, 71, pp.392~402 (2019)
10. Neerinckx B, "Spreading spondyloarthritis: Are ILCs cytokine shuttles from base camp gut?", Ann Rheum Dis, 74, pp.1633~1635 (2015)
11. Tam LS, "Pathogenesis of ankylosing spondylitis", Nat Rev Rheumatol, 6, pp.399~405 (2010)
12. Kilic E, "Bone mass in axial spondyloarthritis : a literature review", World J Orthop, 6, pp.298~310 (2015)
13. Moltó A, "Prevalence of comorbidities and evaluation of their screening in spondyloarthritis : results of the international cross-sectional ASAS-COMOSPA study", Ann Rheum Dis, 75, pp.1016~1023 (2016)
14. Baraliakos X, "What constitutes the fat signal detected by MRI in the spine of patients with ankylosing spondylitis? A prospective study based on biopsies obtained during planned spinal osteotomy to correct hyperkyphosis or spinal stenosis", Ann Rheum Dis, 78, pp.1220~1225 (2019)
15. Kim KW, "Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts", Arthritis Rheum, 64, pp.1015~1023 (2012)
16. Semb AG, "Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis", Nat Rev Rheumatol, 16, pp.361~379 (2020)
17. Tall AR, "Cholesterol, inflammation and innate immunity", Nat Rev Immunol, 15, pp.104~116 (2015)
18. Lacy M, "Interactions between dyslipidemia and the immune system and their relevance as putative therapeutic targets in atherosclerosis", Pharmacol Ther, 193, pp.50~62 (2019)
19. Li Q, "Alteration of circulating innate lymphoid cells in patients with atherosclerotic cerebral infarction", Am J Transl Res, 10, pp.4322~4330 (2018)
20. Sul OJ, "Atherogenic diet-induced bone loss is primarily due to increased osteoclastogenesis in mice", J Nutr Biochem, 79, pp.108337~ (2020)
21. Liu Y, "Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice", Am J Physiol Endocrinol Metab, 310, pp.E762~E773 (2016)
22. Lukas C, "Development of an ASAS-endorsed disease activity score(ASDAS)in patients with ankylosing spondylitis", Ann Rheum Dis, 68, pp.18~24 (2009)
23. 이은정, "2018 Guidelines for the management of dyslipidemia in Korea", The Korean Journal of Internal Medicine, 34(5), pp.1171~1171 (2019), 대한내과학회[DOI]
24. 박영미, "CD36, a scavenger receptor implicated in atherosclerosis", Experimental and Molecular Medicine, 46, pp.1~7 (2014), 생화학분자생물학회
25. Kim MH, "Retinoic acid differentially regulates the migration of innate lymphoid cell subsets to the gut", Immunity, 43, pp.107~119 (2015)
26. Cherrier DE, "Innate lymphoid cell development : a T cell perspective", Immunity, 48, pp.1091~1103 (2018)
27. Ciccia F, "Intestinal dysbiosis and innate immune responses in axial spondyloarthritis", Curr Opin Rheumatol, 28, pp.352~358 (2016)
28. Gill T, "The intestinal microbiome in spondyloarthritis", Curr Opin Rheumatol, 27, pp.319~325 (2015)
29. Breban M, "Faecal microbiota study reveals specific dysbiosis in spondyloarthritis", Ann Rheum Dis, 76, pp.1614~1622 (2017)
30. Gracey E, "Revisiting the gut-joint axis : links between gut inflammation and spondyloarthritis", Nat Rev Rheumatol, 16, pp.415~433 (2020)
31. Agca R, "EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders : 2015", 2016 update, 2017, pp.76, 17~28
32. Rhoads JP, "How oxidized low-density lipoprotein activates inflammatory responses", Crit Rev Immunol, 38, pp.333~342 (2018)
33. Baraliakos X, "Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography", Ann Rheum Dis, 73, pp.1819~1825 (2014)
34. Sherlock JP, "IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8-entheseal resident T cells", Nat Med, 18, pp.1069~1076 (2012)

관련 논문AI추천